Absolutely.
The science looks strong. There is a whole pipeline of possible indications. Patent protection continues to be assigned.
Often, Big Pharma will be willing to buy a company just for one big drug.
With RVX+/-Zenith, they'd be acquiring an entire platform.
FDA approval of BETONMACE would signal to the market that Phase 3 results could lead to FDA approval. Analysts could then truly plug numbers in to their calculators.
Bfw